A detailed history of Icon Wealth Partners, LLC transactions in Repligen Corp stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 1,214 shares of RGEN stock, worth $175,374. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,214
Previous 2,157 43.72%
Holding current value
$175,374
Previous $305,000 36.72%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $130,869 - $166,448
-943 Reduced 43.72%
1,214 $193,000
Q2 2023

Aug 03, 2023

BUY
$138.42 - $180.31 $298,571 - $388,928
2,157 New
2,157 $305,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.